美女免费一级视频在线观看
The Food and Drug Administration issued narrower approvals for new Covid boosters it approved. The agency revoked emergency authorizations for the vaccine, and approved the vaccine for those at higher risk of getting sick (CNBC)
Amylyx halts the development of a rare brain disorder drug program after a trial failure. The therapy was aimed at improving the quality of life of patients with progressive supranuclear palsy (Yahoo! Finance)
The Department of Justice expanded its probe into UnitedHealth Group. The DOJ’s criminal team is also delving into UnitedHealth Group’s prescription management services like Optum Rx. (Bloomberg)
OpenAI tapped leaders from Instagram and Doximity to lead it into the future of healthcare. The company said that it is ramping up its efforts to become a leader in this space. (Business Insider)
Massachusetts’ biopharma industry has shed jobs and hit a new low in funding not seen since 2017, according to a new report released. After years of steady growth, jobs in research and development dropped by roughly 1,100 in 2024 compared to the previous year. (WBUR)
To read yesterday’s edition of Five things for pharma marketers to know, click here.